Someone told you to build a “defensive patent portfolio.”
It sounded responsible. Strategic. The kind of thing a well-run company does. Your attorney nodded. Your board nodded. You started filing patents, not because you planned to enforce them, but because you wanted to have them. Just in case.
You are not alone. I hear this in almost every first conversation with a CEO. “We’re building a defensive portfolio.” When I ask what that means, the answer is always some version of the same thing: “We want to have patents so that if someone comes after us, we have something to point to.”
That is not a strategy. That is a filing habit with a label on it.
What “Defensive” Usually Means
When most people say “defensive,” they mean one of three things.
“We’re not planning to enforce.” Then the patents serve no purpose. A patent is a right to exclude. If you will never exclude anyone, you do not need the right. You have spent $50,000 per patent on a framed certificate.[1]
“We’re filing because investors expect it.” This is signaling, not strategy. It works for a while. Sophisticated investors and acquirers eventually look past the count and ask whether any of the patents constrain a competitor. When the answer is no, the signaling backfires. The portfolio tells the acquirer you spent years filing without analysis.
“We’re afraid to say we’d actually use them.” Enforcement is the point, and enforcement does not mean litigation. It means licensing, cross-licensing, negotiation leverage, competitive positioning.[2] But you have to be willing to act, or the patent is decorative.
None of these are strategies. They are ways to avoid the hard question: does this patent actually do anything?
The White Hat
There is a reason everyone reaches for “defensive,” and it has nothing to do with strategy. “Defensive” wears a white hat. It sounds principled and restrained, the posture of a company that would never be so crude as to go on the attack. Nobody wants to be the aggressor, the litigious one, the company that throws its weight around. So “defensive” becomes a way to hold a stack of patents while disclaiming any intent to ever use them. It is moral cover.
But there is nothing noble about a right you refuse to exercise. A patent is the right to exclude.[3] Choosing never to exclude anyone is not restraint, and it is not virtue. It is paying for a right and then throwing it away. Using your patents does not make you a bully. Licensing, cross-licensing, and negotiating from strength are not unseemly. They are the entire point of the grant. The company that mistakes passivity for principle is not taking the high road. It is the one that gets walked over.
The 400-Page Disclosure Trap
There is a more sophisticated version of the defensive myth, and it is worse.
Some companies, coached by some advisors, file massive patent applications or defensive publications designed to flood the prior art. The theory: dump enough disclosure into the patent record and you block competitors from getting patents in your space. A 400-page specification covering every variation of your technology. A defensive publication with dozens of embodiments. A kitchen-sink provisional stuffed with lab notebooks and speculation.
The theory is seductive. In practice, it is self-destructive.
Here is what actually happens.
Your giant disclosure does land in the prior art, and examiners do find it. They cite it in rejections against your competitors’ applications, and against your own future applications. You have poisoned the well, and you still need to drink from it.
Every future patent you file in the same space now has to navigate around your own prior art. Your own disclosure becomes the reference the examiner uses to reject your own claims. You made the space harder for everyone, including yourself.
And what did you get? Maybe you narrowed a competitor’s claims. You did not get a seat at the table.
Nobody wants to buy, license, or cross-license a 400-page disclosure. It gives you no leverage, no revenue, no enforcement option, no cross-licensing position. When the deal comes, whether an acquisition, a joint venture, a distribution agreement, or a standards pool, you have nothing to trade. You cluttered the landscape and walked away empty-handed.
The competitor whose claims you narrowed still has enforceable patents. Narrower, maybe, but enforceable. They have a seat at the table. You do not.
This is worst for startups and smaller companies.[4] A large company can absorb the cost of poisoning a technology space, because it has thousands of other patents to trade. A startup that dumps its core technology into a massive defensive disclosure gives away its competitive advantage and gets nothing back. The startup needed leverage. It built a public tutorial for its competitors instead.
What “Defensive” Means When It Means Something
There are three real defensive mechanisms, and they all require the same thing: enforceable, licensable patents pointed at the right target.
Cross-licensing leverage. Someone sues you. You countersue with your own patents, or threaten to, and both sides stand down and negotiate a cross-license. This only works if your patents read on the other party’s products. An undetectable patent gives you nothing to countersue with. An unenforceable patent is an empty gun.
Deterrence. Your portfolio discourages competitors from asserting against you in the first place. They know that if they start a fight, you can fight back. Nobody is deterred by weak, unanalyzed patents. They are deterred by patents that would hurt them if asserted.[5]
Competitive positioning. This is the one most people miss, and it is the most powerful.
When you file enforceable patents in a competitor’s technology space, your patents land in their prosecution path. Examiners find your references and use them to narrow the competitor’s claims. Their portfolio gets weaker, not because you asserted anything, but because your published patents constrain what the patent office will grant them.
At the same time, your patents read on their products.[6] Even if you never sue, they change the negotiation for every future deal: distribution agreements, joint ventures, acquisitions, standards pools. Your intellectual property controls more of the landscape, and theirs controls less. When the deal comes, you set the terms.
The difference between this and the 400-page trap is that you have something to show for it. Every patent you filed is enforceable. Every patent is licensable. Every patent is a card you can play. You did not just narrow a competitor’s claims. You built your own position while you did it.
That is what competitive positioning looks like, and it requires the highest-quality patents you can produce.[7] You already spent the effort to develop the ideas. Put them in a form that shapes every future business deal.
“But I Can’t Afford to Enforce”
Here is the objection that ends most of these conversations. “I’ll never have enough money to enforce, so why bother?” So the patents sit unused, and “defensive” becomes the polite word for giving up.
Two things are wrong with that.
First, patent enforcement insurance exists, and it changes the math. It covers the cost of asserting your patents, so you do not need millions of dollars on hand to make an infringer take you seriously. The barrier you are assuming is smaller than you think.
Second, and more important, you do not have to litigate at all to get value from an infringed patent. An infringed patent is an asset. There is a healthy secondary market for patents that read on products already selling,[10] and that value does not depend on you funding a lawsuit. You can sell it. You can borrow against it. You can use it as leverage in a negotiation. A patent that reads on a competitor’s revenue can fund your company whether or not you ever set foot in a courtroom.[11]
That turns the resignation on its head. The reason to build enforceable, detectable patents is not that you plan to sue. It is that an enforceable patent is a real asset and an unenforceable one is not. “I can’t afford to enforce” is not a reason to file weak patents and call them defensive. It is the reason to build patents strong enough that you never have to.
The Same Standards Apply
Here is the part that makes people uncomfortable. There is no category of patent investment where the quality standards do not apply.
Can you detect infringement?[8] A “defensive” patent that fails detectability deters nobody. You cannot countersue with a patent you cannot prove is being infringed.
Who is the infringer? A “defensive” patent whose infringement is split across multiple actors gives you no leverage. The competitor’s attorneys will see the actor problem and dismiss the threat.
Can they design around it?[9] A “defensive” patent a competitor can trivially avoid changes nothing. They design around your claims, file their own patents on the alternative, and you have accomplished nothing.
“Defensive” describes a business purpose. It does not describe a lower quality bar. Every mechanism that makes a patent useful defensively, whether cross-licensing, deterrence, or competitive positioning, requires the patent to be enforceable.
The people who sort patents into “defensive” and “offensive” in their filing decisions are giving themselves permission to file weak ones. They score low on enforceability, then justify the filing by calling it defensive. The label lets them skip the hard questions.
What This Means for Your Portfolio
If someone tells you to build a defensive portfolio without answering these questions, they are selling you wallpaper:
- Which specific competitors does this portfolio target?
- What specific products does each patent read on?
- How would you detect infringement of each patent?
- Who is the single actor you would assert against?
- What negotiation does this patent give you leverage in?
A patent that answers all five is valuable, offensively and defensively. The defensive value is a natural consequence of building enforceable patents in the right space. You do not need a separate strategy for it. You need the same strategy, applied with competitive positioning in mind.
A patent that answers none of them is a cost with no return, whatever you call it.
Build enforceable patents. Point them at the right targets. The defensive value takes care of itself.
1 See BlueIron IP, “Myth: Patents Have Intrinsic Value.” A patent has no value standing alone; its worth comes from the revenue it lets you reach. ↩
2 See BlueIron IP, “How Patent Licensing Works.” ↩
3 See BlueIron IP, “The Patent System Eliminates Monopolies.” A patent is a quid pro quo: you disclose the invention in exchange for a limited right to exclude. ↩
4 See BlueIron IP, “Smaller Companies CAN Use IP to Protect Against Bigger Competitors.” ↩
5 See BlueIron IP, “Patents Give You Defensible Space in Your Market.” A well-built portfolio creates a chilling effect competitors think twice before crossing. ↩
6 See BlueIron IP, “Stop Patenting Your Invention. Patent Your Competitor’s Product.” ↩
7 See BlueIron IP, “Investment-Grade Patents Do Not Have Broad Claims.” ↩
8 See BlueIron IP, “Detectability Is a Key Factor for Patent Value.” ↩
9 See BlueIron IP, “Characteristics of Patents for Designing Good Business,” Investing in Patents, Chapter 2. ↩
10 See BlueIron IP, “How to Find a Realistic Patent Value.” ↩
11 See BlueIron IP, “What an IP-Backed Lender Sees That You Missed.” ↩
